T. Tellez, M. Garcia-Aranda and M. Redondo Pages 4297 - 4308 ( 12 )
Clusterin is a glycoprotein that has been implicated in many processes, including apoptosis, cell cycle regulation and DNA repair. Since clusterin expression has also been associated with tumorigenesis and the progression of various malignancies including prevalent tumors like prostate, colon, bladder and breast, this protein has been proposed as a good candidate for future treatments.
There have been numerous studies conducted in cell lines and xenograft models with successful results that, in general, justify the use of clusterin as a therapeutic target. However, it is still necessary to continue with these studies in order to achieve a better understanding of the role of this protein in carcinogenesis and to determine those specific situations in which its therapeutic use may be more favorable.
In this review, we will make a brief description of clusterin structure and genetics, its implication in tumorigenesis and cancer progression and its prognosis utility. Finally, we will analyze the effects of clusterin inhibition in different types of cancer.
Clusterin, cancer, apoptosis, chemotherapy, antisense oligonucleotides, targeted therapy.
Department of Biochemistry, REDISSEC, Hospital Costa del Sol. Ctra. Cádiz km 187 29600 Marbella, Málaga, Spain.